BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies

alexandrossfakianakis shared this article with you from Inoreader BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies Via Journal of Experimental & Clinical Cancer Research - Latest Articles Colorectal cancer (CRC) harboring BRAFV600E mutation exhibits low response to conventional therapy and poorest prognosis. Due to the emerging correlation between gut microbiota and CRC carcinogenesis, we investig... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.